• Building on the results of the Azithromycin Prevention in Labour Use Study (A-Plus), a study found that providing pregnant women delivering vaginally with an oral dose of azithromycin is an economical approach to lower the risk of infection, sepsis, and mortality in the mother.

• For 91 cents per pregnancy, the study showed that this intervention averted 249 maternal hospitalizations, and 1592 incidents of maternal sepsis, infection, and mortality.

• $32,661 was saved overall for every 100,000 pregnancies.

• According to the primary author, this can assist ministries in low and middle-income countries (LMICs), which have twice the prevalence of chronic diseases as affluent countries, in cost-effectively allocating their limited resources.

Click here to read more